BioLineRx (BLRX) Interest Expenses (2013 - 2025)
BioLineRx (BLRX) recorded quarterly Interest Expenses of -$280000.0 in Q4 2025, up 7.89% quarter-over-quarter from -$304000.0 in Q3 2025, and up 93.75% on a YoY basis from -$144516.1 in Q4 2024.
BioLineRx (BLRX) Interest Expenses (2013 - 2025) Analysis & Trends
BioLineRx's Interest Expenses history runs 13 years deep, the most recent figure standing at -$280000.0 for Q4 2025.
- In Q4 2025, Interest Expenses rose 93.75% year-over-year to -$280000.0; the TTM figure through Dec 2025 stood at -$1.3 million (up 85.96% YoY), while the FY2025 annual figure was -$1.3 million, up 85.96% from the prior year.
- Interest Expenses was -$280000.0 for Q4 2025 at BioLineRx, up from -$304000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $932000.0 in Q4 2023 to a low of -$4.5 million in Q4 2024.
- Historically, Interest Expenses has averaged -$786600.0 across 5 years, with a median of -$341500.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses soared 170.29% in 2023, then sank 580.69% in 2024.
- A 5-year view of Interest Expenses shows it stood at -$204000.0 in 2021, then slumped by 550.0% to -$1.3 million in 2022, then jumped by 170.29% to $932000.0 in 2023, then tumbled by 580.69% to -$4.5 million in 2024, then jumped by 93.75% to -$280000.0 in 2025.
- The last three Interest Expenses figures came in at -$280000.0 (Q4 2025), -$304000.0 (Q3 2025), and -$276000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | BioLineRx | 227.63 Mn | 211.90 Mn | 154,000.00 | -280,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -280,000.00 |
| Dec 31, 2025 | -280,000.00 |
| Sep 30, 2025 | -304,000.00 |
| Sep 30, 2025 | -304,000.00 |
| Jun 30, 2025 | -276,000.00 |
| Jun 30, 2025 | -276,000.00 |
| Mar 31, 2025 | -420,000.00 |
| Mar 31, 2025 | -420,000.00 |
| Dec 31, 2024 | -4.48 Mn |
| Dec 31, 2024 | -4.48 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Sep 30, 2024 | -1.63 Mn |
| Jun 30, 2024 | -2.09 Mn |
| Jun 30, 2024 | -2.09 Mn |
| Mar 31, 2024 | -929,000.00 |
| Mar 31, 2024 | -929,000.00 |
| Dec 31, 2023 | 932,000.00 |
| Dec 31, 2023 | 932,000.00 |
| Sep 30, 2023 | -837,000.00 |
| Sep 30, 2023 | -837,000.00 |